World Cancer Day is more than just a day on the calendar – and for Pfizer Gulf, delivering meaningful breakthroughs, empowering communities and closing the care gap are the critical driving forces behind its enduring commitment to patients in the UAE.
It is a day to raise hopes, inspire change and mobilize action long after the day itself – which is why the world’s premier biopharma company marked the occasion this year by renewing its vital partnerships with UAE-based cancer patient societies; Emirates Oncology Society (EOS) and Friends of Cancer Patients (FOCP).
As part of the memoranda of understanding (MoUs) signed with FOCP and EOS, Pfizer will lend its support to raise awareness, encourage early detection and support the treatment of cancer in the UAE, reinforcing its commitment to advancing oncology care in the country.
ABU DHABI, 23rd December, 2021 (WAM) The Department of Health – Abu Dhabi (DoH) has announced a new collaboration with Pfizer to develop national competencies and clinical research capacity in Abu Dhabi.
In the presence of Abdulla bin Mohamed Al Hamed, Chairman of DoH and Sean Murphy, Charge d’Affaires at the US Embassy, a Declaration of Collaboration between the two entities was signed by Dr. Jamal Mohammed Al Kaabi, Under-Secretary of DoH and Lindsey Dietschi, Gulf Cluster Lead.
The mutual agreement will focus on.